生物活性 | |||
---|---|---|---|
描述 | SB-659032 is a selective and orally active inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) that is being developed for the treatment of atherosclerosis. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.36mL 0.27mL 0.14mL |
6.80mL 1.36mL 0.68mL |
13.59mL 2.72mL 1.36mL |
参考文献 |
---|